Barclays’s DTRT Health Acquisition Corp. Class A Common Stock DTRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-521,762
Closed -$5.3M 5484
2022
Q3
$5.3M Buy
521,762
+321,762
+161% +$3.25M 0.01% 1123
2022
Q2
$2.01M Hold
200,000
﹤0.01% 1846
2022
Q1
$2.01M Buy
+200,000
New +$2M ﹤0.01% 1861

Other funds holding DTRT

Barclays's DTRT Position: Q4 2022 in Review

Barclays sold out of DTRT Health Acquisition Corp. Class A Common Stock (DTRT) in Q4 2022, closing a stake of 521,762 shares — an estimated $5.3M sold.

Barclays first reported a position in DTRT in Q1 2022 and held it in 3 quarters. The position peaked at $5.3M in Q3 2022. 17 funds tracked by Wall St. Rank hold DTRT as of Q4 2022.

  • Barclays reported no remaining DTRT Health Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Barclays sold 521,762 DTRT Health Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $5.3M.
  • Barclays first reported a position in DTRT Health Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 3 quarters.
  • Barclays's DTRT Health Acquisition Corp. Class A Common Stock position peaked at $5.3M in Q3 2022.
  • 17 funds tracked by Wall St. Rank held DTRT Health Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.